Re-comparing of three different epidemic seasons of bronchiolitis: different prophylaxis approaches

During the last epidemic season of bronchiolitis (S2, years 2016–2017) we performed a single Centre analysis in inborn infant of 30(+ 0)–32(+ 6) gestational age and age < 12 months who did not receive prophylaxis with palivizumab (PLV), in light of the current AIFA (Italian Drug Agency) guideline...

Descripción completa

Detalles Bibliográficos
Autores principales: Picone, Simonetta, Fabiano, Adele, Roma, Davide, Di Palma, Federico, Paolillo, Piermichele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292081/
https://www.ncbi.nlm.nih.gov/pubmed/30541607
http://dx.doi.org/10.1186/s13052-018-0593-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292081/
https://www.ncbi.nlm.nih.gov/pubmed/30541607
http://dx.doi.org/10.1186/s13052-018-0593-7

Ejemplares similares